#NEWS : Bayer is committed in advancing novel options in #Ophthalmology that address unmet needs for patients with retinal diseases, their carers and healthcare professionals.
The #ARVO Annual Meeting addresses how vision research is continually being transformed.

#NEWS : We are thrilled to share our latest collaboration with Google Cloud on the development of artificial intelligence ( #AI ) solutions to support radiologists and ultimately better serve patients.
#BayerInRadiology #GoogleCloudNext

#NEWS : Bayer and Thermo Fisher Scientific collaborate to increase patient access to precision cancer medicines by offering decentralized genomic testing and rapid turnaround time.
Learn more: bayer.com/media/en-us/
#TeamBayer #cdx #precisionmedicine #oncology

This @WorldKidneyDay we stand with the kidney disease community in highlighting the need for equitable access to care. Hear from Dr Markus Scheerer, Vice President CKD, Global Medical Affairs, who shares his expert thoughts on how we can achieve #KidneyHealthForAll .

+++ #NEWS +++
Bayer and AIGNOSTICS partner on next generation precision oncology.
Learn more: bayer.com/media/
#teambayer

#NEWS : The prestigious Lancet journal has published clinical trial data of a compound in two major retinal eye diseases. This scientific publication describes extended treatment intervals aiming to alleviate the burden of disease.
Learn more: bayer.com/media/en-us/

Pipeline #news : BlueRock Therapeutics Phase I clinical trial in #Parkinson ’s disease keeps breaking ground. The investigational #celltherapy continues to show positive trends in clinical trials, and we look forward to moving forward to Phase II later this year: bayer.com/en/media

+++ #NEWS : Update on our Cardiology Portfolio! +++

We are thrilled to share that we are partnering with BridgeBio Pharma with the aim to bring new #cardiology treatment options to patients in need.

Learn more: spr.ly/6010Xk2ci

#TeamBayer #HeartHealth #PatientCare

+++ Pipeline #news +++
FDA grants #BreakthroughTherapy designation to Bayer's oral, reversible tyrosine kinase inhibitor being developed for non-small cell lung cancer ( #NSCLC ) harboring HER2 mutations.

Learn more: spr.ly/6016nI0Se
#TeamBayer

+++ Pipeline #news +++
Bayer announced today the start of a Phase II trial with
an investigational first-in-class anti-alpha2 antiplasmin antibody in patients with deep vein thrombosis. Learn more: spr.ly/6018nuTd2
#TeamBayer

Pipeline #news : Vividion Therapeutics Therapeutics, Inc., our chemoproteomics platform company starts Phase I clinical trial with second oncology program addressing high profile #cancer target in #patients with advanced solid and hematologic tumors.
Learn more: bayer.com/media/en-us/

.Ambassador Amy Gutmann Dr. Amy Gutmann shared her family's story of survival during the Holocaust. For Holocaust Remembrance Day, use the hashtag #WeRemember to ensure that the memory of the victims and survivors of the Shoah are never forgotten.

Learn more at AboutHolocaust.org

#NEWS : China’s Regulatory Authority accept Bayer AG’s application for regulatory approval of a new formulation with the potential to reduce disease burden in exudative retinal disease.
This supports our commitment to a better patient care in #Ophthalmology : bayer.com/media/en-us/

+++ #News +++
Today, the regulatory authority in Japan granted market authorization for a new option in two major retinal eye diseases.
This supports our commitment to better patient care in #Ophthalmology . #TeamBayer
Learn more: bayer.com/media/en-us/

+++Exciting #news +++
Bayer AG starts Phase II study to evaluate its non-hormonal investigational treatment option in women with sleep disturbances associated with menopause.

Learn more: bit.ly/News_Bayer

#WomensHealth #TeamBayer #HealthForAll #HungerForNone #JPM2024

+++ #Newsflash +++
Bayer AG and RTW Investments, LP Lead Series D Financing in Chinese biotech Jixing Pharmaceuticals.
Learn more: bayer.com/en/media

What are main challenges in women’s health, and gender equity, in aging societies? Yesmean H. Wahdan, MD, VP US Medical Affairs - Women’s Healthcare at Bayer AG, joins the stage at #SEF2023 with National Menopause Foundation Major League Soccer Bank of America, hosted by #GCOA .

shorturl.at/jNOT9

How can people age better and healthier? Dr. Mike Devoy, Chief Medical Officer Bayer AG, discusses this and other questions on #HealthyAging at this year‘s Silver Economy Forum in New York. #SEF2023 #AgingForAllAges

event.silvereconomyforum.com/events/better-…

Diabetes & high blood pressure doesn’t just affect your patients’ day-to-day life, they put them at risk of #CKD . 🩺 Monitor kidney function and kidney damage in these patients.

Join our kidney community: bit.ly/3PVTY3w

#ThinkKidneyCare

Nie wieder ist JETZT!
Mehr Infos unter Niewiederistjetztberlin.de